Amphista has been one of Maxion Therapeutics's top competitors. Amphista's headquarters is in Cambridge, England, and was founded in 2017. Like Maxion Therapeutics, Amphista also competes in the Biotechnology field. Amphista generates 521% of Maxion Therapeutics's revenue.
Nurix is one of Maxion Therapeutics's top rivals. Nurix is a Public company that was founded in San Francisco, California in 2009. Like Maxion Therapeutics, Nurix also works within the Biotechnology industry. Nurix has 291 more employees vs. Maxion Therapeutics.
DiogenX is perceived as one of Maxion Therapeutics's biggest rivals. DiogenX was founded in 2019, and is headquartered in Marseille, Other. Like Maxion Therapeutics, DiogenX also competes in the Biotechnology sector. DiogenX generates $1.1M less revenue vs. Maxion Therapeutics.